|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 11/04/14 Healthcare Realty Trust Inc 10-Q 9/30/14 49:7.7M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 483K
4: EX-33.1 Report of Compliance with Servicing Criteria HTML 24K
2: EX-31.2 Certification -- §302 - SOA'02 HTML 24K
3: EX-32 Certification -- §906 - SOA'02 HTML 21K
31: R1 Document and Entity Information HTML 36K
23: R2 Condensed Consolidated Balance Sheets (Unaudited) HTML 105K
29: R3 Condensed Consolidated Balance Sheets HTML 38K
(Parenthetical)
33: R4 Condensed Consolidated Statements of Operations HTML 119K
(Unaudited)
45: R5 Condensed Consolidated Statements of Comprehensive HTML 26K
Income (Loss) (Unaudited)
24: R6 Condensed Consolidated Statements of Cash Flows HTML 130K
(Unaudited)
28: R7 Summary of Significant Accounting Policies HTML 33K
21: R8 Real Estate Investments HTML 229K
15: R9 Notes and Bonds Payable HTML 25K
46: R10 Commitments and Contingencies HTML 21K
35: R11 Equity HTML 189K
34: R12 Defined Benefit Pension Plan HTML 40K
39: R13 Fair Value of Financial Instruments HTML 35K
40: R14 Summary of Significant Accounting Policies HTML 38K
(Policies)
38: R15 Real Estate Investments (Tables) HTML 213K
41: R16 Equity (Tables) HTML 186K
30: R17 Defined Benefit Pension Plan (Tables) HTML 37K
32: R18 Fair Value of Financial Instruments (Tables) HTML 32K
37: R19 Summary of Significant Accounting Policies HTML 33K
(Details)
49: R20 Real Estate Investments - Assets acquired and HTML 44K
liabilities assumed (Details)
43: R21 Real Estate Investments - Discontinued Operations HTML 50K
and Assets Held for Sale - Balance Sheet (Details)
26: R22 Real Estate Investments - Discontinued Operations HTML 78K
and Assets Held for Sale - Income Statement
(Details)
36: R23 Real Estate Investments - Narrative (Details) HTML 162K
27: R24 Real Estate Investments - Acquisitions (Details) HTML 42K
14: R25 Real Estate Investments - Dispositions (Details) HTML 37K
44: R26 Notes and Bonds Payable (Details) HTML 44K
47: R27 Equity - Reconciliation of total stockholders' HTML 77K
equity (Details)
18: R28 Equity - Change in ownership of HTML 31K
less-than-wholly-owned subsidiary (Details)
17: R29 Equity - Reconciliation of beginning and ending HTML 27K
common stock outstanding (Details)
19: R30 Equity - Computation of basic and diluted earnings HTML 84K
(Loss) Per Common Share (Details)
20: R31 Equity - Summary of activity under stock-based HTML 31K
incentive plans (Details)
22: R32 Equity - Summary of activity under Employee Stock HTML 36K
Purchase Plan (Details)
12: R33 Equity (Stock Transactions - Narrative) (Details) HTML 43K
42: R34 Defined Benefit Pension Plan (Details) HTML 35K
25: R35 Fair Value of Financial Instruments (Details) HTML 29K
48: XML IDEA XML File -- Filing Summary XML 71K
11: EXCEL IDEA Workbook of Financial Reports XLSX 155K
16: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.18M
5: EX-101.INS XBRL Instance -- hr-20140930 XML 1.75M
7: EX-101.CAL XBRL Calculations -- hr-20140930_cal XML 182K
8: EX-101.DEF XBRL Definitions -- hr-20140930_def XML 490K
9: EX-101.LAB XBRL Labels -- hr-20140930_lab XML 1.27M
10: EX-101.PRE XBRL Presentations -- hr-20140930_pre XML 729K
6: EX-101.SCH XBRL Schema -- hr-20140930 XSD 124K
13: ZIP XBRL Zipped Folder -- 0000899749-14-000042-xbrl Zip 180K
| HR-2014.9.30-Ex311 |
1. | I
have reviewed this quarterly report on Form 10-Q of Healthcare Realty Trust Incorporated; |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects
the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed
such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial
reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change
in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The
registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record,
process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: | ||
/s/ DAVID R. EMERY | ||
Chairman of the Board and Chief Executive Officer | ||
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/4/14 | 3, 8-K | ||
| For Period end: | 9/30/14 | 4 | ||
| List all Filings | ||||